125 related articles for article (PubMed ID: 722500)
1. GLC determination of tilidine, nortilidine, and bisnortilidine in biological fluids with a nitrogen-sensitive detector.
Hengy H; Vollmer KO; Gladigau V
J Pharm Sci; 1978 Dec; 67(12):1765-8. PubMed ID: 722500
[TBL] [Abstract][Full Text] [Related]
2. Gas-chromatographic determination of nanogram amounts of enantiomers of nortilidine, a main metabolite of tilidine, in biological specimens.
Hengy H; Vollmer KO; Gladigau V
Clin Chem; 1978 Apr; 24(4):692-7. PubMed ID: 639277
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a GLC-NPD method with a GLC-MS-SIM procedure for the determination of tilidine and its metabolites in plasma.
Cordonnier J; Wauters A; Heyndrickx A
J Anal Toxicol; 1987; 11(4):144-8. PubMed ID: 3626526
[TBL] [Abstract][Full Text] [Related]
4. Disposition of tilidine in a fatal poisoning in man.
Cordonnier J; Van den Heede M; Heyndrickx A; Wennig R
J Anal Toxicol; 1987; 11(3):105-9. PubMed ID: 3599916
[TBL] [Abstract][Full Text] [Related]
5. Sequential first-pass metabolism of nortilidine: the active metabolite of the synthetic opioid drug tilidine.
Hajda JP; Jähnchen E; Oie S; Trenk D
J Clin Pharmacol; 2002 Nov; 42(11):1257-61. PubMed ID: 12412825
[TBL] [Abstract][Full Text] [Related]
6. Rapid quantification of tilidine, nortilidine, and bisnortilidine in urine by automated online SPE-LC-MS/MS.
Köhler C; Grobosch T; Binscheck T
Anal Bioanal Chem; 2011 Apr; 400(1):17-23. PubMed ID: 21140136
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of tilidine in terminal renal failure.
Seiler KU; Jähnchen E; Trenk D; Brennscheidt U; Heintz B
J Clin Pharmacol; 2001 Jan; 41(1):79-84. PubMed ID: 11144998
[TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatographic determination of tilidine in pharmaceutical dosage forms.
Zivanov-Stakić D; Solomun LJ; Zivanović LJ
Farmaco; 1989; 44(7-8):759-62. PubMed ID: 2590373
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of tilidine and metabolites in man.
Vollmer KO; Thomann P; Hengy H
Arzneimittelforschung; 1989 Oct; 39(10):1283-8. PubMed ID: 2610722
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability investigation of a new tilidine/naloxone liquid formulation compared to a reference formulation.
Martin W; Ring J; Gaupp M; Arnold P; Sennewald R; Doser K
Arzneimittelforschung; 1999 Jul; 49(7):599-607. PubMed ID: 10442208
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of tilidine and naloxone in patients with severe hepatic impairment.
Brennscheidt U; Brunnmüller U; Proppe D; Thomann P; Seiler KU
Arzneimittelforschung; 2007; 57(2):106-11. PubMed ID: 17396621
[TBL] [Abstract][Full Text] [Related]
12. Pre-systemic elimination of tilidine: localization and consequences for the formation of the active metabolite nortilidine.
Eichbaum C; Mathes K; Burhenne J; Markert C; Blank A; Mikus G
Basic Clin Pharmacol Toxicol; 2015 Feb; 116(2):129-33. PubMed ID: 25223231
[TBL] [Abstract][Full Text] [Related]
13. GLC determination of floxuridine in plasma using a thermionic nitrogen detector.
De Leenheer AP; Gelijkens CF
J Pharm Sci; 1978 Mar; 67(3):417-9. PubMed ID: 147936
[TBL] [Abstract][Full Text] [Related]
14. Determination of cyproheptadine in plasma and urine by GLC with a nitrogen-sensitive detector.
Hucker HB; Hutt JE
J Pharm Sci; 1983 Sep; 72(9):1069-70. PubMed ID: 6631695
[TBL] [Abstract][Full Text] [Related]
15. GLC method for the quantification of metabolites of thymoxamine in human plasma.
Hengy H; Von Hodenberg A; Vollmer KO
Eur J Drug Metab Pharmacokinet; 1985; 10(3):203-8. PubMed ID: 2935399
[TBL] [Abstract][Full Text] [Related]
16. An automated and fully validated LC-MS/MS procedure for the simultaneous determination of 11 opioids used in palliative care, with 5 of their metabolites.
Musshoff F; Trafkowski J; Kuepper U; Madea B
J Mass Spectrom; 2006 May; 41(5):633-40. PubMed ID: 16541404
[TBL] [Abstract][Full Text] [Related]
17. Trace determination of chlorpheniramine in plasma by GLC using a nitrogen-phosphorous (N-P) detector.
Smith HT; Jacob JT; Achari RG
J Chromatogr Sci; 1978 Nov; 16(11):561-4. PubMed ID: 730818
[TBL] [Abstract][Full Text] [Related]
18. A GLC-nitrogen phosphorous detector assay for trifluoperazine in plasma.
Roscoe RM; Cooper JK; Hawes EM; Midha KK
J Pharm Sci; 1982 Jun; 71(6):625-7. PubMed ID: 7097522
[TBL] [Abstract][Full Text] [Related]
19. [Management of chronic pain using extended release tilidine : Quality of life and implication of comedication on tilidine metabolism].
Wolfert C; Merbach M; Stammler G; Emrich O; Meid AD; Burhenne J; Blank A; Mikus G
Schmerz; 2017 Oct; 31(5):516-523. PubMed ID: 28597312
[TBL] [Abstract][Full Text] [Related]
20. A death case involving tilidine.
Van Boven M; Daenens P; Bruneel N
Arch Toxicol; 1976 Oct; 36(2):121-5. PubMed ID: 1036886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]